🥚💰 ONEGO BIO RAISES €14M FOR ANIMAL-FREE EGG PROTEIN Three months after raising $40M in its Series A round, Finnish precision fermentation player Onego Bio has brought in another €14M ($15.2M) to scale up production and fuel its EU plans. The latest capital injection comes from the European Innovation Council’s (EIC) Accelerator Programme and additional Series A investors, taking the total raised by the startup to $70.8M. It comes as Onego Bio gears up for a North American launch, expecting to achieve self-determined Generally Recognized as Safe (GRAS) status for its Bioalbumen protein in the US this year, with a ‘no further questions’ letter from the US FDA anticipated in 2025. The EIC financing will also be used to drive its launch strategy in the EU, where it plans to submit a dossier for novel food approval to the European Food Safety Authority (EFSA). Eventualy, it aims to enter the South American and Asian markets as well. Onego Bio was one of 68 companies that attracted investment from the EIC scheme. A total of 969 startups had initially submitted proposals, 347 of which were interviewed by juries of investors and entrepreneurs. Of the selected companies, only 21% were women-led – but one of these is Onego Bio. With egg prices regularly fluctuating due to an unstable supply chain, innovations like Onego Bio’s are crucial for a resilient food system. Currently, it is producing the Bioalbumen with co-manufacturers and finalising plans for its own manufacturing unit. Read the full article here: https://lnkd.in/eurivRRD #GreenQueen #futurefoods #foodtech #sustainability #innovation
Congrats Maija Itkonen 💯
Thank you Green Queen Media for sharing our exciting news! 🥚